The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Uranova N.A.

Nauchnyĭ tsentr psikhicheskogo zdorov'ia RAMN, Moskva

Kolomeets N.S.

Nauchnyĭ tsentr psikhicheskogo zdorov'ia RAMN, Moskva

Vikhreva O.V.

Nauchnyĭ tsentr psikhicheskogo zdorov'ia RAMN, Moskva

Zimina I.S.

Nauchnyĭ tsentr psikhicheskogo zdorov'ia RAMN, Moskva

Rakhmanova V.I.

Nauchnyĭ tsentr nevrologii RAMN, Moskva

Orlovskaia D.D.

Nauchnyĭ tsentr psikhicheskogo zdorov'ia RAMN, Moskva

Ultrastructural changes of myelinated fibers in the brain in continuous and attack-like paranoid schizophrenia

Authors:

Uranova N.A., Kolomeets N.S., Vikhreva O.V., Zimina I.S., Rakhmanova V.I., Orlovskaia D.D.

More about the authors

Read: 754 times


To cite this article:

Uranova NA, Kolomeets NS, Vikhreva OV, Zimina IS, Rakhmanova VI, Orlovskaia DD. Ultrastructural changes of myelinated fibers in the brain in continuous and attack-like paranoid schizophrenia. S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(2):104‑109. (In Russ.)
https://doi.org/10.17116/jnevro201711721104-109

Recommended articles:

References:

  1. Uranova NA, Vikhreva OV, Rachmanova VI, Orlovskaya DD. Ultrastructural alterations of myelinated fibers and oligodendrocytes in the prefrontal cortex in schizophrenia: a postmortem morphometric study. Schizophrenia Research and Treatment. 2011;1-13. (In Russ.).
  2. Uranova NA, Kolomeets NS, Vikhreva OV, Zimina IS, Rachmanova VI, Orlovskaya DD. Ultrastructural pathology of myelinated fibers in schizophrenia. Zh Nevrol Psikhiatr Im S.S. Korsakova. 2013;113(9):63-69. (In Russ.).
  3. Kolomeets NS, Uranova NA. Pathology of oligodendroglia and myelinated fibers of the hippocampus in schizophrenia (an ultrastructural and morphometric study). Zh Nevrol Psikhiatr Im S.S. Korsakova. 2008;108(8):52-60. (In Russ.).
  4. Glezer II, Sukhorukova LI. Structural features of neuroglia in schizophrenia of the periodic and uninterruped types (histological and electron microscopic study). Zh Nevropatol Psikhiatr Im S.S. Korsakova. 1966;66(10):1529-1537. (In Russ.).
  5. Sukhorukova LI. Changes in neuroglia in continuous schizophrenia. Zh Nevropatol Psikhiatr Im S.S. Korsakova. 1966;66(9):1408-1416. (In Russ.).
  6. Davis JM. Dose equivalence of the antipsychotic drugs. Journal of Psychiatry Research. 1974;11:65-69.
  7. Rey MJ, Schulz P, Costa C, Dick P, Tissot R. Guidelines for the dosage of neuroleptics. I: сhlorpromazine equivalents of orally administered neuroleptics. International Clinical Psychopharmacology. 1989;4(2):95-104.
  8. Woods SW. Chlorpromazine equivalent doses for the newer atypical antipsychotics. Journal of Clinical Psychiatry. 2003;64(6):663-667.
  9. Uranova N, Orlovskaya D, Vikhreva O, Zimina I, Kolomeets N, Vostrikov V, Rachmanova V. Electron microscopy of oligodendroglia in severe mental illness. Brain Research Bulletin. 2001;55:597-610.
  10. Hof PR, Haroutunian V, Friedrich VLJr, Byne W, Buitron C, Perl DP, Davis KL. Loss and altered spatial distribution of oligodendrocytes in the superior frontal gyrus in schizophrenia. Biological Psychiatry. 2003;53:1075-1085.
  11. Uranova NA, Vostrikov VM, Orlovskaya DD, Rachmanova VI. Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium. Schizophrenia Research. 2004;67(2-3):269-275.
  12. Vostrikov VM, Uranova NA, Orlovskaya DD. Deficit of perineuronal oligodendrocytes in the prefrontal cortex in schizophrenia and mood disorders. Schizophrenia Research. 2007;94(1-3):273-280.
  13. Falkai P, Malchow B, Wetzestein K, Nowastowski V, Bernstein HG, Steiner J, Schneider-Axmann T, Kraus T, Hasan A, Bogerts B, Schmitz C, Schmitt A. Decreased Oligodendrocyte and Neuron Number in Anterior Hippocampal Areas and the Entire Hippocampus in Schizophrenia: A Stereological Postmortem Study. Schizophrenia Bulletin. 2016;42(suppl 1):4-12. doi:10.1093/schbul/sbv157
  14. Falkai P, Steiner J, Malchow B, Shariati J, Knaus A, Bernstein HG, Schneider-Axmann T, Kraus T, Hasan A, Bogerts B, Schmitt A.Oligodendrocyte and Interneuron Density in Hippocampal Subfields in Schizophrenia and Association of Oligodendrocyte Number with Cognitive Deficits. Frontiers Cellular Neuroscience. 2016;10:78. doi:10.3389/fncel.2016.00078. eCollection 2016
  15. Hakak Y, Walker JR, Li C, Wong WH, Davis KL, Buxbaum JD, Haroutunian V, Fienberg AA. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proceedings of National Academy of Science USA. 2001;98:4746-4751.
  16. Haroutunian V, Katsel P, Dracheva S, Stewart DG, Davis KL. Variations in oligodendrocyte-related gene expression across multiple cortical regions: implications for the pathophysiology of schizophrenia. International Journal of Neuropsychopharmacology. 2007;10:565-573.
  17. Casaccia-Bonnefil P. Cell death in the oligodendrocyte lineage: a molecular perspective of life/death decisions in development and disease. Glia. 2000;29:124-135.
  18. Jamin N, Junier MP, Grannec G, Cadusseau J. Two temporal stages of oligodendroglial response to excitotoxic lesion in the gray matter of the adult rat brain. Experimental Neurology. 2001;172:17-28.
  19. Gallinat J, McMahon K, Kühn S, Schubert F, Schaefer M. Cross-sectional Study of Glutamate in the Anterior Cingulate and Hippocampus in Schizophrenia. Schizophrenia Bulletin. 2016;42(2):425-433. doi:10.1093/schbul/sbv124
  20. Tamminga CA, Southcott S, Sacco C, Wagner AD, Ghose S. Glutamate dysfunction in hippocampus: relevance of dentate gyrus and CA3 signaling. Schizophrenia Bulletin. 2012;38(5):927-935. doi:10.1093/schbul/sbs062
  21. Burbaeva GSh, Boksha IS, Turishcheva MS, Vorobyeva EA, Savushkina OK, Tereshkina EB. Glutamine synthetase and glutamate dehydrogenase in the prefrontal cortex of patients with schizophrenia. Progress in Neuropsychopharmacology and Biological Psychiatry. 2003;27:675-680.
  22. Tiganov AS. Psychiatry. Part I. Textbook for psychiatrists in two parts. M.: Medicine; 2012. (In Russ.).
  23. Vikhreva OV, Rakhmanova VI, Orlovskaya DD, Uranova NA. Ultrastructural alterations of oligodendrocytes in prefrontal white matter in schizophrenia: A post-mortem morphometric study. Schizophrenia Research. 2016. pii: S0920-9964(16)30173-6 doi: 10.1016/j.schres.2016.04.023
  24. Steiner J, Bielau H, Brisch R, Danos P, Ullrich O, Mawrin C, Bernstein HG, Bogerts B. Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide. Journal of Psychiatry Research. 2008;42(2):151-157.
  25. Busse S, Busse M, Schiltz K, Bielau H, Gos T, Brisch R, Mawrin C, Schmitt A, Jordan W, Müller UJ, Bernstein HG, Bogerts B, Steiner J. Different distribution patterns of lymphocytes and microglia in the hippocampus of patients with residual versus paranoid schizophrenia: further evidence for disease course-related immune alterations? Brain, Behavior, and Immunology. 2012;26(8):1273-1279. doi:10.1016/j.bbi.2012.08.005
  26. Kolomeets NS. The role of microglia reactivity in the cerebral pathology in schizophrenia. Zh Nevrol Psikhiatr Im S.S. Korsakova. 2009;109(3):60-63. (In Russ.).

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.